Physician profile
Phyllis T Losikoff
NPI 1548215338
$152,883.76
in general payments reported to CMS, 2019-2025
6 companies · $27K in 2025
The $27K reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $7,944 · 2021: $5,196 · 2022: $14K · 2023: $39K · 2024: $49K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $73K · Travel and Lodging: $20K · Consulting Fee: $19K · Food and Beverage: $2,871 · Education: $18.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $72,910.00 |
| Travel and Lodging | $20,330.30 |
| Consulting Fee | $18,870.00 |
| Food and Beverage | $2,870.87 |
| Education | $18.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $152,497.09 | 2019-2025 | Epclusa |
| Braeburn INC. | $260.48 | 2024-2025 | Brixadi |
| Alkermes, INC. | $48.08 | 2019-2024 | Vivitrol |
| Orexo US, INC. | $29.77 | 2019 | |
| Abbvie INC. | $24.97 | 2019 | |
| Hikma Pharmaceuticals USA | $23.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phyllis Losikoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.